Brind.

Kadant, News Corp, Cencora, and Royalty Pharma were identified as high-quality stocks operating in the pharmaceutical industry.

1 report, 0 independent Updated Jun 26

AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

SpeculativeNo independent reporting found

Who's involved

What this event is mainly about

Kadant Cencora Royalty Pharma

Keep exploring

The entities involved

Kadant
US-based paper company

Nothing else this week.
Cencora
US drug wholesale company company
- Trump's tariff plan caused market tanking, an event that occurred on August 22, 2025.Sun 04:29
Royalty Pharma
biopharmaceutical company based in New York City
- Visteon filed transaction details with the SEC and traded on the Nasdaq stock exchange on June 6, 2026.Sun 17:49
- Royalty Pharma acquired a royalty interest in Amgen's drug Imdelltra.Sun 02:34

Coverage

Newest first; wire copies grouped

Jun 26Unknown outlet